GlassScriptPhysician profile
Dara W Botts
NPI 1982826004
$47,222.29
in general payments reported to CMS, 2019-2025
59 companies · $2,188 in 2025
The $2,188 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17K · 2022: $22K · 2023: $3,650 · 2024: $3,001 · 2025: $2,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,246 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,245.53 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,593.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $31,347.51 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Zealand Pharma US, INC. | $5,129.32 | 2021-2022 | |
| Corcept Therapeutics | $1,989.80 | 2021-2025 | Korlym |
| Astrazeneca Pharmaceuticals LP | $965.60 | 2021-2025 | Farxiga, Lokelma, Breztri |
| Lilly USA, LLC | $884.76 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Beta Bionics, INC. | $685.58 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Amgen INC. | $580.77 | 2021-2024 | Repatha, Otezla |
| Sanofi-Aventis U.S. LLC | $549.43 | 2021-2025 | |
| Mannkind Corporation | $430.78 | 2021-2025 | Afrezza |
| Xeris Pharmaceuticals, INC. | $428.52 | 2021-2025 | Gvoke Hypopen |
| Insulet Corporation | $350.75 | 2021-2025 | Omnipod |
| Abbvie INC. | $327.03 | 2021-2025 | |
| Medtronic, INC. | $312.00 | 2021-2025 | Minimed 780g |
| Cequr Corporation | $272.89 | 2023-2025 | Cequr Simplicity |
| Abbott Laboratories | $272.16 | 2021-2025 | Freestyle Libre 3 |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dara Botts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.